Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Speculative
Why I would add Althea and these small cap ASX healthcare shares to your watchlist
Share Market News
Starpharma share price jumps after cancer drug trial approval
Share Gainers
ALL ORDINARIES finishes lower Tuesday: 8 shares you missed
Share Market News
Starpharma shares lift on trading update
Share Market News
Is the Starpharma share price a buy?
Share Gainers
ALL ORDINARIES finishes higher Thursday: 8 shares you missed
Share Gainers
Why the Starpharma share price raced 5% higher today
Share Gainers
Why Bravura, Bubs, LiveTiles, & Starpharma shares charged higher today
Share Gainers
Why Eclipx, REA Group, Regis Resources, & Starpharma shares zoomed higher today
Share Fallers
Starpharma share price zooms higher following AstraZeneca agreement
Share Gainers
Why the Starpharma share price charged 11% higher today
Share Gainers
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
